Patents by Inventor Robert A. O'Neill

Robert A. O'Neill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120175315
    Abstract: A process for dewatering oil sand fine tailings is provided and comprises a dispersion and floc build-up stage comprising in-line addition of a flocculent solution comprising an effective amount of flocculation reagent into a flow of the oil sand fine tailings; a gel stage wherein flocculated oil sand fine tailings is transported in-line and subjected to shear conditioning; a floc breakdown and water release stage wherein the flocculated oil sand fine tailings releases water and decreases in yield shear stress, while avoiding an oversheared zone; depositing the flocculated oil sand fine tailings onto a deposition area to form a deposit and to enable the release water to flow away from the deposit, preferably done in a pipeline reactor and managing shear according to yield stress and CST information and achieves enhanced dewatering.
    Type: Application
    Filed: April 22, 2010
    Publication date: July 12, 2012
    Applicant: SUNCOR ENERGY INC.
    Inventors: Adrian Peter Revington, Oladipo Omotoso, Patrick Sean Wells, Thomas Charles Hann, Marvin Harvey Weiss, Trevor Bugg, Jamie Eastwood, Stephen Joseph Young, Hugues Robert O'Neill, Ana Cristina Sanchez
  • Patent number: 7632801
    Abstract: The present invention relates to the identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. Interfering compounds that inhibit viral replication can be used therapeutically to treat viral infection. The invention is based, in part, on the Applicants' discovery of novel interactions between viral proteins and a human host cell proteins. One of these host cell proteins, referred to herein as NPI-1, interacts with influenza virus protein NP. Also, host cell proteins, referred to herein as NS1I-1 and NS1-BP interact with influenza virus protein NS1. In addition, host cell proteins containing WW domains that interact with viral proteins such as Rhabdoviral M protein are described.
    Type: Grant
    Filed: January 6, 2003
    Date of Patent: December 15, 2009
    Assignee: Mount Sinai School of Medicine of New York University
    Inventors: Peter M. Palese, Robert O'Neill, Ronald Harty
  • Patent number: 7498424
    Abstract: The present invention relates to the identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. Interfering compounds that inhibit viral replication can be used therapeutically to treat viral infection. The invention is based, in part, on the Applicants' discovery of novel interactions between proteins of the influenza virus and a human host cell proteins. One of these host cell proteins, referred to herein as NPI-1, interacts with influenza virus protein NP, and may be an accessory protein required for replication of influenza virus. Another of these host cell proteins, referred to herein as NS1I-1, interacts with influenza virus protein NS1. Compounds that interfere with the binding of the host cell and viral proteins, and inhibit viral replication can be useful for treating viral infection in vivo.
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: March 3, 2009
    Assignee: Mount Sinai School of Medicine of New York University
    Inventors: Peter Palese, Robert O'Neill
  • Publication number: 20060208565
    Abstract: A brake assembly includes a mounting plate, pressure members disposed in a substantially coplanar manner relative to the mounting plate, and electric actuators mounted to the mounting plate. The electric actuators are configured to selectively move the pressure members relative to the mounting plate (i) from a non-braking position to a braking position in response to a first command, and (ii) from the braking position to the non-braking position in response to a second command. Such a brake assembly is well-suited for a variety of applications including vehicle brakes such as aircraft brakes.
    Type: Application
    Filed: March 16, 2005
    Publication date: September 21, 2006
    Inventor: Robert O'Neill
  • Publication number: 20050191703
    Abstract: The present invention relates to the identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. Interfering compounds that inhibit viral replication can be used therapeutically to treat viral infection. The invention is based, in part, on the Applicants' discovery of novel interactions between proteins of the influenza virus and a human host cell proteins. One of these host cell proteins, referred to herein as NPI-1, interacts with influenza virus protein NP, and may be an accessory protein required for replication of influenza virus. Another of these host cell proteins, referred to herein as NS1I-1, interacts with influenza virus protein NS1. Compounds that interfere with the binding of the host cell and viral proteins, and inhibit viral replication can be useful for treating viral infection in vivo.
    Type: Application
    Filed: November 24, 2003
    Publication date: September 1, 2005
    Inventors: Peter Palese, Robert O'Neill
  • Patent number: 6890710
    Abstract: The present invention relates to the identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. Interfering compounds that inhibit viral replication can be used therapeutically to treat viral infection. The invention is based, in part, on the Applicants' discovery of novel interactions between proteins of the influenza virus and a human host cell proteins. One of these host cell proteins, referred to herein as NPI-1, interacts with influenza virus protein NP, and may be an accessory protein required for replication of influenza virus. Another of these host cell proteins, referred to herein as NS1I-1, interacts with influenza virus protein NS1. Compounds that interfere with the binding of the host cell and viral proteins, and inhibit viral replication can be useful for treating viral infection in vivo.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: May 10, 2005
    Assignee: Mount Sinai School of Medicine of New York University
    Inventors: Peter Palese, Robert O'Neill
  • Publication number: 20050033009
    Abstract: A polyurethane-polymer composition suitable for preparing a lightweight tire support includes at least one isocyanate, at least one polyol, and at least one chain extender. A polyurethane-polymer composition can also include an additive such as a catalyst, a filler, a surfactant, a colorant, and a mold-release agent. A lightweight tire support can be prepared from a polyurethane-polymer composition by, for example, reaction injection molding. Such a tire support desirably has temperature stability and load-bearing capability.
    Type: Application
    Filed: September 16, 2004
    Publication date: February 10, 2005
    Inventors: Alan Schrock, Ralph Priester, Wayne Willkom, Robert O'Neill, Martin Cornell, Christopher Christenson
  • Publication number: 20030232325
    Abstract: The present invention relates to the identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. Interfering compounds that inhibit viral replication can be used therapeutically to treat viral infection. The invention is based, in part, on the Applicants' discovery of novel interactions between viral proteins and a human host cell proteins. One of these host cell proteins, referred to herein as NPI-1, interacts with influenza virus protein NP. Also, host cell proteins, referred to herein as NS1I-1 and NS1-BP interact with influenza virus protein NS1. In addition, host cell proteins containing WW domains that interact with viral proteins such as Rhabdoviral M protein are described.
    Type: Application
    Filed: January 6, 2003
    Publication date: December 18, 2003
    Applicant: Mount Sinai School of Medicine of New York University
    Inventors: Peter M. Palese, Robert O'Neill, Ronald Harty
  • Patent number: 6503703
    Abstract: The present invention relates to the identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. Interfering compounds that inhibit viral replication can be used therapeutically to treat viral infection. The invention is based, in part, on the Applicants' discovery of novel interactions between viral proteins and a human host cell proteins. One of these host cell proteins, referred to herein as NPI-1, interacts with influenza virus protein NP. Also, host cell proteins, referred to herein as NS1I-1 and NS1-BP interact with influenza virus protein NS1. In addition, host cell proteins containing WW domains that interact with viral proteins such as Rhabdoviral M protein are described.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: January 7, 2003
    Assignee: Mount Sinai School of Medicine of New York University
    Inventors: Peter M Palese, Robert O'Neill, Ronald Harty
  • Patent number: 5750394
    Abstract: The present invention relates to the identification of host cell proteins that interact with viral proteins required for virus replication, and high throughput assays to identify compounds that interfere with the specific interaction between the viral and host cell protein. Interfering compounds that inhibit viral replication can be used therapeutically to treat viral infection.The invention is based, in part, on the discovery described herein of a novel interaction between the NP of influenza virus and a human host cell protein. The host cell protein, referred to herein as NPI-1, may be an accessory protein required for replication of influenza virus. Compounds that interfere with the binding of the host cell and viral proteins, and inhibit viral replication can be useful for treating viral infection in vivo.
    Type: Grant
    Filed: May 20, 1994
    Date of Patent: May 12, 1998
    Assignee: The Mount Sinai Medical Center
    Inventors: Peter Palese, Robert O'Neill
  • Patent number: 5701356
    Abstract: The transducer support assembly includes a transducer secured to a U-shaped strap having a pair of chest engageable leg portions connected integrally to a curved neck engageable portion by a pair of twisted intermediate portions for engaging the body of the user. The chest engageable leg portions are adapted to fit over the shoulders and to lie substantially flat against the chest of the user. A wide portion of the neck engageable portion extends in overlying substantially continuous engagement with the neck or back of the user to resist the chest engageable leg portions from swinging away from the chest. A gripping material forms an underside surface of the strap to frictionally engage the user, thereby inhibiting the strap from moving relative to the body of the user. Another transducer support assembly includes a flexible U-shaped neck support having a chest engageable portion.
    Type: Grant
    Filed: December 5, 1995
    Date of Patent: December 23, 1997
    Assignee: HM Electronics
    Inventors: Thomas H. Stanford, Farhad Noroozi Sahne, Thomas P. Riches, Robert O'Neill
  • Patent number: 5448235
    Abstract: A method and system are provided for marking marine channels. A single laser beam is selectively interrupted to produce an identifying on/off laser beam sequence distinguishable by the human eye. The laser beam is then expanded in terms of beam diameter during specifically timed periods of laser beam transmission. The expanded laser beam is projected along a beam path that is substantially along the center of a marine channel to be marked at a height above the water's surface. The height of the beam path is selected such that marine traffic may pass under the beam path without obstructing same.
    Type: Grant
    Filed: August 30, 1993
    Date of Patent: September 5, 1995
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Robert O'Neill, Jr., Judith B. Snow
  • Patent number: 4829280
    Abstract: An element protector control for protecting the electrically powered heating element of a kettle against overheating has primary and secondary (or back-up) modes of operation. The primary protection mode utilizes a dished, snap-acting bimetal which is oriented so that the side of the bimetal which is convex when the blade is cold faces the heating element head, and the bimetal is sprung against a flat rear surface of the element head so that the bimetal in its cold condition flattens against the element head. The bimetal determines the condition of a pair of switching contacts provided in the control.
    Type: Grant
    Filed: July 28, 1987
    Date of Patent: May 9, 1989
    Assignee: Otter Controls Limited
    Inventors: Arthur M. Blackburn, Robert A. O'Neill, Terence J. C. Foster, Ian G. White